Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ken Mohler"'
Publikováno v:
Toxicologic pathology. 30(3)
Periosteal hyperostosis (exostosis) was identified in 5.9% (11/188) of DBA/1 male mice 10—14 weeks old used for collagen-induced arthritis (CIA) efficacy testing of immunomodulatory biologics. Mice with and without CIA in the affected limb, and als
Autor:
Linda Park, Terri Davis Smith, Ken Mohler, Mary Gerhart, Craig A. Smith, Ken Schooley, Pamela J. Smolak, David J. Pickup, Heidi Hagen, Dauphine Torrance, Della Friend, Raymond G. Goodwin
Publikováno v:
Virology. 236(2)
Poxvirus genomes encode several proteins which inhibit specific elements of the host immune response. We show the "35K" virulence gene in variola and cowpox viruses, whose vaccinia and Shope fibroma virus equivalents are strongly conserved in sequenc
Autor:
Kathy Barrett, M. Patricia Beckmann, C. Paul Chow, William C. Fanslow, Adriano Fontana, Michael Fountoulakis, Brian Foxwell, Karl Frei, Gianni Garotta, Reiner Gentz, Georges E. Grau, James D. Green, Cindy A. Jacobs, Thomas C. Jones, Steven L. Kunkel, Paul-Henri Lambert, Gerhard Leitz, David H. Lynch, Charles R. Maliszewski, M.J. Mihatsch, Ken Mohler, Laurence Ozmen, Hans-Walter Pfister, Daniela Piani, Pierre-François Piguet, Daniel G. Remick, Frank Rosenkaimer, Antal Rot, Bernhard Ryffel, Gerhard G. Steinmann, Angelika C. Stern, Timothy G. Terrell, Pierre Vassalli, Alfred Walz, Peter K. Working, Roland Zwahlen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2e3689a1997934a62fd1568b49e3f3a
https://doi.org/10.1016/b978-0-12-364935-5.50004-3
https://doi.org/10.1016/b978-0-12-364935-5.50004-3
Publikováno v:
The Journal of Immunology. 184:96.25-96.25
SMIP molecules are single chain binding proteins based on a scFv-CH2-CH3 format. We have generated SMIP proteins using binding domains from well characterized mitogenic and non-mitogenic anti-CD3 antibodies, and have found dramatic differences in the
Publikováno v:
The Journal of Immunology. 184:145.30-145.30
The T cell receptor complex (TCR) is a powerful therapeutic target for modulating autoimmunity and transplantation biology. A number of studies have shown that TCR/CD3-directed molecules are beneficial in mouse models of disease (e.g, acute graft vs
Autor:
Yuhua, Zhang, Jun, Xu, Jeremy, Levin, Martin, Hegen, Guangde, Li, Heidi, Robertshaw, Fionula, Brennan, Terri, Cummons, Dave, Clarke, Nichole, Vansell, Cheryl, Nickerson-Nutter, Dauphine, Barone, Ken, Mohler, Roy, Black, Jerry, Skotnicki, Jay, Gibbons, Marc, Feldmann, Philip, Frost, Glenn, Larsen, Lih-Ling, Lin
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics; April 2004, Vol. 309 Issue: 1 p348-55, 8p